Anti-IFNAR1 Neutralizing Antibody (V3S-0622-YC4567) (CAT#: V3S-0622-YC4567)

Send Inquiry
  • fig1
    Figure 1 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in SDS-PAGE.
  • fig1
    Figure 2 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in SEC-HPLC.
  • fig1
    Figure 3 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in ELISA.

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with IFNAR1. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application FuncS; IF; Neut; ELISA; FC; IP; IHC
Application Notes The antibody is recommended for detection of IFNAR1 by FuncS, IF, Neut, ELISA, FC, IP, IHC assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IFNAR1
Alternative Name AVP; IFRC; IFNAR; IFNBR; IFN-alpha-REC
Gene ID 3454
UniProt P17181
Research Area Immunology; Signal Pathway

Tested Data

SDS-PAGE

Figure 1 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in SDS-PAGE.

SDS-PAGE analysis of V3S-0622-YC4567 in β-mercaptoethanol-reduced (Lane 1, 1.5 μg) and non-reduced (Lane 2, 1.5 μg) conditions.

Figure 1 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in SDS-PAGE.

SEC-HPLC

Figure 2 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in SEC-HPLC.

The purity of V3S-0622-YC4567 was greater than 95% as determined by SEC-HPLC.

Figure 2 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in SEC-HPLC.

ELISA

Figure 3 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in ELISA.

ELISA analysis of V3S-0622-YC4567 was performed by coating with recombinant IFNAR protein, His tag.

Figure 3 Anti-IFNAR1 Neutralizing Antibody(V3S-0622-YC4567) in ELISA.

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry